Abstract
Dopamine receptor genes are known to be candidate genes, mutations of which may be involved in the development of cardiovascular diseases. The human D4 receptor gene (DRD4) contains a variable number (two to ten copies) of tandem 48-bp repeats in exon 3. The goal of the study was to analyze the association of DRD4 gene polymorphism with cardiovascular disease risk factors in the Russian population: blood pressure (BP), high-density (HDL) and low-density (LDL) lipoprotein cholesterol levels, and the triglyceride level. We genotyped 257 women and 425 men for variable number tandem repeat polymorphism in DRD4. The subjects were Novosibirsk residents of Slavic ethnicity. They were divided either into 7+ (those having the allele of seven or eight repeats) and 7–(two to six repeats) groups or into 2+5+ (two or five repeats) and 2–5–(three, four, six, seven, or eight repeats) groups. We found associations between the 7+ allele and elevated systolic and diastolic BP in women but not in men. Neither sex showed associations between the long variants of the DRD4 gene and pulse blood pressure. The presence of the 2–or 5–allele of the DRD4 polymorphism was associated with low HDL cholesterol levels in women and low total cholesterol levels in men. The polymorphism exerted no significant effects on LDL, HDL, or triglyceride levels in men.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ainiyet, B. and Rybakowski, J.K., Suicidal behavior in schizophrenia may be related to low lipid levels, Med. Sci. Monit., 2014, vol. 20, pp. 1486–1490. Bgee. 2014. http://bgeeunilch/bgee/bgee
Borinskaya, S.A., Kozhekbaeva, Zh.M., Gorbunova, E.V., et al., Analysis of the DRD4 gene polymorphism in populations of Russia and neighboring countries, Russ. J. Genetics, 2004, vol. 40, no. 6, pp. 679–683.
Brunerova, L., Potockova, J., Horacek, J., et al., Central dopaminergic activity influences metabolic parameters in healthy men, Neuroendocrinology, 2013, vol. 97, no. 2, pp. 132–138.
Camont, L., Chapman, M.J., and Kontush, A., Biological activities of hdl subpopulations and their relevance to cardiovascular disease, Trends Mol. Med., 2011, vol. 17, no. 10, pp. 594–603.
Cipolletta, E., Ciccarelli, M., Izzo, R., et al., A polymorphism within the promoter of the dopamine receptor D1 (DRD1-48A/G) associates with impaired kidney function in white hypertensive patients, Transl. Med. UniSa, 2012, vol. 2, pp. 10–19.
Dason, J.S., Smith, A.J., Marin, L., and Charlton, M.P., Cholesterol and f-actin are required for clustering of recycling synaptic vesicle proteins in the presynaptic plasma membrane, J. Physiol., 2014, vol. 592, no. 4, pp. 621–633.
Diffenderfer, M.R. and Schaefer, E.J., The composition and metabolism of large and small LDL, Curr. Opin. Lipidol., 2014, vol. 25, no. 3, pp. 221–226.
Elovainio, M., Puttonen, S., Heponiemi, T., et al., Relationship between DRD4 polymorphism and lipid metabolism: what is the role of novelty seeking, Neuropsychobiology, 2005, vol. 51, no. 1, pp. 53–58.
Fang, Y.J., Thomas, G.N., Xu, Z.L., et al., An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension, J. Cardiol., 2005, vol. 102, no. 1, pp. 111–116.
Gafarov, V.V., Gromova, E.A., Voevoda, M.I., et al., Epidemiological, genetic features of personal anxiety as a risk factor for stroke (WHO “MONICA-psychosocial”), Cerebrovasc. Dis., 2013, vol. 35, suppl. 3, p. 428.
Gold, M.S., Blum, K., Oscar-Berman, M., and Braverman, E.R., Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?, Postgrad. Med., 2014, vol. 126, no. 1, pp. 153–177.
Grady, D.L., Thanos, P.K., Corrada, M.M., et al., DRD4 genotype predicts longevity in mouse and human, J. Neurosci., 2013, vol. 33, no. 1, pp. 286–291.
Graham, G., Population-based approaches to understanding disparities in cardiovascular disease risk in the united states, Int. J. Gen. Med., 2014, vol. 7, pp. 393–400.
Keck, T.M., Suchland, K.L., Jimenez, C.C., et al., Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate, Pharmacol. Biochem. Behav., 2013, vol. 103, no. 4, pp. 831–841.
Lamon-Fava, S., Ordovas, J.M., and Schaefer, E.J., Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter, Arterioscler. Thromb. Vasc. Biol., 1999, vol. 19, no. 12, pp. 2960–2965.
Louis-Dit-Picard, H., Barc, J., Trujillano, D., et al., KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron, Nat. Genet., 2012, vol. 44, no. 4, pp. 456–460.
Luepker, R.V., WHO MONICA project: what have we learned and where to go from here?, Pub. Health Rev., 2012, vol. 33, no. 2, pp. 373–396.
Maxwell, A., Are some individuals diagnosed with ADHD prone to alcohol abuse? Consideration of two possible mediating factors for this susceptibility, J. Atten. Disord., 2013, vol. 17, no. 2, pp. 98–101.
Munafo, M.R., Yalcin, B., Willis-Owen, S.A., and Flint, J., Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data, Biol. Psychiatry, 2008, vol. 63, no. 2, pp. 197–206.
Nanko, S., Hattori, M., Ikeda, K., et al., Dopamine D4 receptor polymorphism and schizophrenia, Lancet, 1993, vol. 341, no. 8846, pp. 689–690.
Nemoda, Z., Szekely, A., and Sasvari-Szekely, M., Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood, Neurosci. Biobehav. Rev., 2011, vol. 35, no. 8, pp. 1665–1686.
Nikolaidis, A. and Gray, J.R., ADHD and the DRD4 exon III 7-repeat polymorphism: an international metaanalysis, Soc. Cogn. Affect. Neurosci., 2010, vol. 5, nos. 2/3, pp. 188–193.
O’Meara, N.M., Devery, R.A., Owens, D., et al., Alterations in cellular cholesterol metabolism following administration of 6-hydroxydopamine to rabbits, Br. J. Pharmacol., 1992, vol. 105, no. 2, pp. 495–499.
Orth, M. and Bellosta, S., Cholesterol: its regulation and role in central nervous system disorders, Cholesterol, 2012, vol. 2012, p. 292598.
Orun, O., Nacar, C., Cabadak, H., et al., Investigation of the association between dopamine D1 receptor gene polymorphisms and essential hypertension in a group of Turkish subjects, Clin. Exp. Hypertens., 2011, vol. 33, no. 6, pp. 418–421.
Polymeropoulos, M.H., Licamele, L., Volpi, S., et al., Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia, Schizophr. Res., 2009, vol. 108, nos. 1–3, pp. 134–142.
Pucadyil, T.J. and Chattopadhyay, A., Role of cholesterol in the function and organization of G-protein coupled receptors, Prog. Lipid Res., 2006, vol. 45, no. 4, pp. 295–333.
Ricci, A., Marchal-Victorion, S., Bronzetti, E., et al., Dopamine D4 receptor expression in rat kidney: evidence for preand postjunctional localization, J. Histochem. Cytochem., 2002, vol. 50, no. 8, pp. 1091–1096.
Rotella, J.A., Zarei, F., Frauman, A.G., and Greene, S.L., Refractory hypotension treated with vasopressin after intentional clozapine overdose, Eur. J. Emerg. Med., 2014, vol. 21, no. 4, pp. 319–320.
dos Santos Silva, C.M., Barbosa, F.R., Lima, G.A., et al., BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists, Obesity, 2011, vol. 19, no. 4, pp. 800–805.
Sen, S., Nesse, R., Sheng, L., et al., Association between a dopamine-4 receptor polymorphism and blood pressure, Am. J. Hypertens., 2005, vol. 18, no. 9, pp. 1206–1210.
Staruschenko, A., Regulation of transport in the connecting tubule and cortical collecting duct, Compar. Physiol., 2012, vol. 2, no. 2, pp. 1541–1584.
Tayebati, S.K., Lokhandwala, M.F., and Amenta, F., Dopamine and vascular dynamics control: present status and future perspectives, Curr. Neurovasc. Res., 2011, vol. 8, no. 3, pp. 246–257.
Wang, X., Ding, X., Su, S., et al., Genetic influence on blood pressure measured in the office, under laboratory stress and during real life, Hypertens. Res., 2011, vol. 34, no. 2, pp. 239–244.
Wu, J., Xiao, H., Sun, H., et al., Role of dopamine receptors in ADHD: a systematic meta-analysis, Mol. Neurobiol., 2012, vol. 45, no. 3, pp. 605–620.
Zeng, C., Zhang, M., Asico, L.D., et al., The dopaminergic system in hypertension, Clin. Sci., 2007, vol. 112, no. 12, pp. 583–597.
Zeng, C., Armando, I., Luo, Y., et al., Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice, Am. J. Physiol. Heart Circ. Physiol., 2008, vol. 294, no. 2, pp. H551–H569.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.S. Yudin, T.M. Mishakova, E.V. Ignatieva, V.N. Maksimov, V.V. Gafarov, S.K. Malyutina, M.I. Voevoda, 2014, published in Vavilovskii Zhurnal Genetiki i Selektsii, 2014, Vol. 18, No. 4/3, pp. 1259–1267.
Rights and permissions
About this article
Cite this article
Yudin, N.S., Mishakova, T.M., Ignatieva, E.V. et al. Association of dopamine receptor D4 (DRD4) gene polymorphism with cardiovascular disease risk factors. Russ J Genet Appl Res 5, 650–655 (2015). https://doi.org/10.1134/S2079059715060192
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079059715060192